Spotlight On: Mia Femtech

Published

Written by...

Share this article

A look at the science behind the UK’s first minimally invasive breast implant technology

For many years, surgical implantation has been the only go-to option for breast augmentation. In 2024, this changed when the first minimally-invasive breast implant technology was launched to the UK market.
Created by aesthetic treatment company Mia Femtech, this technology features the first injectable, biocompatible implants designed for a natural look and feel, setting a new standard in aesthetics.1,2 These injectable implants can provide patients with a one or two cup enhancement.3
How it works
The implant used in the procedure (the Ergonomix2 Diamond implant) is uniquely designed to produce a greater projection than a conventional round implant.4 The biaxial symmetry of the implant may reduce or eliminate malpositions in the event of implant flipping.5
Mia utilises a patented tissue preservation technique that eliminates the need for cutting breast tissue. Instead, the procedure employs hydro-dissection and inflatable balloon expansion to create…

Subscriber content

Continue reading this clinical article

To read this post in full you need an Aesthetics Journal subscription. Choose the plan that fits your practice — every paid plan includes the complete peer-reviewed clinical library and CPD-accredited learning.